These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 702235)

  • 1. Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies.
    Krause PJ; Cherry JD; Naiditch MJ; Deseda-Tous J; Walbergh EJ
    J Pediatr; 1978 Oct; 93(4):565-71. PubMed ID: 702235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories.
    Krause PJ; Cherry JD; Carney JM; Naiditch MJ; O'Connor K
    Am J Dis Child; 1980 Jun; 134(6):567-71. PubMed ID: 7386428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of measles antibody after revaccination.
    Markowitz LE; Albrecht P; Orenstein WA; Lett SM; Pugliese TJ; Farrell D
    J Infect Dis; 1992 Jul; 166(1):205-8. PubMed ID: 1607699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical measles in adolescent siblings 16 years after killed measles virus vaccine.
    Fulginiti VA; Helfer RE
    JAMA; 1980 Aug 22-29; 244(8):804-6. PubMed ID: 7392190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five cases of measles secondary vaccine failure with confirmed seroconversion after live measles vaccination.
    Hirose M; Hidaka Y; Miyazaki C; Ueda K; Yoshikawa H
    Scand J Infect Dis; 1997; 29(2):187-90. PubMed ID: 9181657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.
    Ward BJ; Boulianne N; Ratnam S; Guiot MC; Couillard M; De Serres G
    J Infect Dis; 1995 Dec; 172(6):1591-5. PubMed ID: 7594723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further-attenuated measles vaccine: characteristics and use.
    Krugman S
    Rev Infect Dis; 1983; 5(3):477-81. PubMed ID: 6879002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exaggerated natural measles following attenuated virus immunization.
    St Geme JW; George BL; Bush BM
    Pediatrics; 1976 Jan; 57(1):148-9. PubMed ID: 1246490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus.
    Norrby E; Enders-Ruckle G; Meulen V
    J Infect Dis; 1975 Sep; 132(3):262-9. PubMed ID: 1159329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles vaccines used in Japan.
    Hirayama M
    Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe local reactions to live measles virus vaccine following an immunization program.
    Stetler HC; Gens RD; Seastrom GR
    Am J Public Health; 1983 Aug; 73(8):899-900. PubMed ID: 6223536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of single-component measles vaccine in school children.
    Tosun S; Olut AI; Tansug N
    Vaccine; 2017 Dec; 35(52):7309-7311. PubMed ID: 29128384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
    Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
    Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety and immunogenicity of measles attenuated live vaccine prepared by master seed lot vaccine of Shanghai-191 strain].
    Zhang SJ; Xiao QY; Li FJ
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):423-5. PubMed ID: 20084967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.